Synthesis, bioactivity, and molecular docking studies: novel arylpiperazine derivatives as potential new-resistant AR antagonists. [PDF]
Jiang H, Chen H, Wang Y, Xu H, Chen H.
europepmc +1 more source
Bioisosteric Replacement of Amides with 1,2,3-Triazoles Improves Dopamine D4 Receptor Ligand Pharmacokinetics. [PDF]
Alkhatib M +24 more
europepmc +1 more source
Green synthesis of 1,3,5-triazine derivatives using a sonochemical protocol. [PDF]
Kułaga D +8 more
europepmc +1 more source
Hybrid design reveals a dopamine D3R ligand with promising in vitro ADME properties. [PDF]
Namballa HK +6 more
europepmc +1 more source
CXCR3 inhibitors for therapeutic interventions: current status and perspectives. [PDF]
Huo R, Jiang Y, Zhang L, Du S, Zhou D.
europepmc +1 more source
Identification of oxyresveratrol, a food-as-medicine substrate, as a novel EPI that targets the RND efflux pumps of <i>Serratia surfactantfaciens</i> sp. nov. YD25<sup>T</sup>. [PDF]
Liu F +8 more
europepmc +1 more source
Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants. [PDF]
Pham VT +4 more
europepmc +1 more source
A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes. [PDF]
Michel MC, Michel-Reher MB, Hein P.
europepmc +1 more source
Regulation, structure, and activity of the <i>Pseudomonas aeruginosa</i> MexXY efflux system. [PDF]
Kavanaugh LG +3 more
europepmc +1 more source
Synthesis and evaluation of arylpiperazines derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR ligands. [PDF]
Kumar JSD +3 more
europepmc +1 more source

